Skip to content

Lexical Priming by Music in Alzheimer's Disease and Healthy Aging

Lexical Priming by Music in Alzheimer's Disease and Healthy Aging

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03342326
Acronym
PriMus
Enrollment
58
Registered
2017-11-14
Start date
2018-04-03
Completion date
2019-05-29
Last updated
2020-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Keywords

Lexical priming, Healthy Aging

Brief summary

While verbal memory is quickly reached in the wake of Alzheimer's disease, the musical memory remains preserved until a late stage of the disease. This observation encouraged the development of music-based therapies in the management of neurocognitive and behavioral disorders that characterize Alzheimer's disease. In order to develop rehabilitation programs that effectively target cognitive functions to stimulate, it is necessary to understand the mechanisms underlying this beneficial effect of music on cognition.

Detailed description

The investigators study the stimulation by the song, material integrating language and music, and having an autobiographical value. The investigators measure the lexical priming capacity of the song, that is, its ability to activate and maintain lexical and semantic representations, which are threatened with alteration in the course of the disease. This lexical priming effect by song is measured in patients with mild Alzheimer's disease and healthy volunteers during a single test session. In the first phase of the session, participants are exposed to familiar songs, presented in sung, spoken or instrumental form, whose popularity they evaluate. In the second phase, they perform two implicit memory tasks: a trigram completion task and a lexical decision task. These tests measure the facilitation of the processing of words evoked by songs in relation to words unrelated to songs, reflecting a long-term memory update of mnemic traces of primed words.

Interventions

OTHERExposure to familiar songs

3 conditions : a) Words and Music (sing condition), b) Words only (spoken condition) and c) Music only (instrumental condition) After each song : rate the popularity of the song on a scale of 1 to 5.

OTHERMusic Experience Questionnaire

questions about the past music training

OTHERImplicit tasks memory

2 tests : a) Completion of trigrams : freely complete the first 3 letters of a word. b) lexical decision : judge whether an audibly presented sound sequence is a word existing in the French language or not.

OTHERQuestionnaires

Mini Mental State Examination, 5 words by Dubois and fluence verbal test

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for patients : * Presence of diagnostic criteria for Alzheimer's disease * Age ≥ 65 years * MMSE (Mini-mental state Examination) ≥ 20

Exclusion criteria

for patient : * Unstable clinical presentation or language presentation in the foreground * Cognitive disorder of etiology different from that of Alzheimer's disease Inclusion Criteria for volunteers : * Age ≥ 18 years * Absence of neurological or psychiatric antecedents * For those aged 65 or over: MMSE (Mini-mental state Examination) greater than or equal to 27; non-pathological performance against the 5 words of Dubois and the verbal fluency test.

Design outcomes

Primary

MeasureTime frame
Reaction time difference for the treatment of words that have been presented in sing condition in the exposure phase versus words presented in spoken condition.Day 1

Secondary

MeasureTime frame
Reaction time difference for processing words associated with songs presented by their melody alone versus new words (not presented in the exhibition phase).Day 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026